S06 Neuromodulation vs. Lesioning for the Management of Pain

3:30 PM - 5:00 PM Saturday, July 17

Neuromodulation is a re-emerging part of the treatment for the management of chronic pain disorders. At the same time, the importance of appropriately indicated lesioning procedures remains understated. Data from well-designed trials appears promising and hopes to provide insight into appropriate target selection. This session will discuss innovative targeting for the treatment of chronic pain, explore potential mechanisms of action, and discuss high-yield case presentations.

CME Credits: 1.5 AMA PRA Category 1 CreditsTM

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Describe when lesioning versus stimulation is appropriate to manage chronic pain.
  • Explain the difference between cancer versus non-cancer pain and nuances involved in treatment.
  • Discuss the current literature and evidence to aid in target selection for treatment of pain.


Michael D. Staudt, MD, MSc

Rushna P. Ali, MD

Stimulation vs. Lesioning: Target Selection, Current Evidence, and Practice Parameters for Management of Cancer Pain

Amitabh Gulati, MD

Tailoring DBS for Chronic Pain

Prasad Shirvalkar, MD,PHD

Case Discussions 1: Lesioning vs. Stimulation for Long-Term Management of Cancer Pain

Ahmed Raslan, MD

Case Discussions 2: Lesioning vs. Stimulation for Long-Term Management of Non-Cancer Pain

Konstantin V. Slavin, MD

Faculty and Presentations subject to change.